Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

Skin symptoms can indicate endocrine disorders and have various treatments.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

Polymeric nanoparticles show promise for treating skin diseases.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

PRP and cell therapies may help with hair loss, but more research is needed.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Minoxidil is effective for promoting hair growth and has various dermatological uses.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Melasma treatment is difficult, but combination therapies and personalized plans show promise.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Zinc is effective for treating various skin conditions, including warts and acne.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.